Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Comparison of IgG serum antibodies, electronic health records and self-report in estimating past infection with Chlamydia trachomatis in a cohort of men who have sex with men

Mary Bridget Waters https://orcid.org/0000-0001-5624-5443 A * , Lindley A. Barbee https://orcid.org/0000-0002-7189-5492 B C , Kevin Hybiske B , Katherine Newman B , Ren Ikeda B , Angela LeClair B , Matthew R. Golden A B C , Olusegun O. Soge B D E , Lisa E. Manhart A and Christine M. Khosropour A
+ Author Affiliations
- Author Affiliations

A Department of Epidemiology, University of Washington, Seattle, WA, USA.

B Department of Medicine, University of Washington, Seattle, WA, USA.

C Public Health – Seattle and King County, HIV/STD Program, Seattle, WA, USA.

D Department of Global Health, University of Washington, Seattle, WA, USA.

E Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

* Correspondence to: mbwaters@uw.edu

Handling Editor: Michael Marks

Sexual Health 21, SH24101 https://doi.org/10.1071/SH24101
Submitted: 10 May 2024  Accepted: 14 November 2024  Published: 2 December 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing

Abstract

Background

The best method for measuring a history of Chlamydia trachomatis (CT) infections is unknown. We examined the reliability of three methods as markers of past CT infections: IgG serum antibodies, the electronic health record (EHR) and self-report.

Methods

This cross-sectional study used data from a cohort study of 122 MSM in King County, Washington, United States. Sera were tested for IgG using the mixed CT peptide enzyme-linked immunosorbent assay (ELISA). Participant data for past CT diagnoses were extracted from the EHR. Self-report of past CT was collected via survey. We calculated positive and negative percent agreements of CT history using total IgG serum antibodies to CT, past EHR diagnosis and self-report of past CT as reference measures when they were compared with one another.

Results

Of those who were IgG seropositive, only 41.5% had a past diagnosis of CT in their EHRs, but 74.4% self-reported a history of CT. The majority (92.7%) of participants who had a diagnosis of CT in their EHRs reported a past CT infection.

Conclusions

Self-report in combination with IgG serum antibodies to CT may be a more reliable indicator of past CT than EHRs in settings without comprehensive EHRs.

Keywords: antibodies, chlamydia trachomatis, EHR, epidemiology, men who have sex with men, past infection, self-report, sexually transmitted infections.

References

Hornberger LL, Rosenthal SL, Biro FM, Stanberry LR. Sexual histories of adolescent girls: comparison between interview and chart. J Adolesc Health 1995; 16: 235-239.
| Crossref | Google Scholar |

Clark LR, Brasseux C, Richmond D, Getson P, D’angelo LJ. Are adolescents accurate in self-report of frequencies of sexually transmitted diseases and pregnancies? J Adolesc Health 1997; 21: 91-96.
| Crossref | Google Scholar |

Harrington KF, Diclemente RJ, Wingood GM, et al. Validity of self-reported sexually transmitted diseases among African American female adolescents participating in an HIV/STD prevention intervention trial. Sex Transm Dis 2001; 28(8): 468-471.
| Crossref | Google Scholar | PubMed |

Dariotis JK, Pleck JH, Sonenstein FL, Astone NM, Sifakis F. What are the consequences of relying upon self-reports of sexually transmitted diseases? Lessons learned about recanting in a longitudinal study. J Adolesc Health 2009; 45(2): 187-192.
| Crossref | Google Scholar |

Cunningham NJ, Beymer MR, Javanbakht M, Shover CL, Bolan RK. Concordance between self-reported STI history and biomedical results among men who have sex with men in Los Angeles, California. Sex Transm Infect 2017; 93(7): 514-519.
| Crossref | Google Scholar | PubMed |

Fennema JS, Van Ameijden EJ, Coutinho RA, Van Den Hoek JA. Validity of self-reported sexually transmitted diseases in a cohort of drug-using prostitutes in Amsterdam: trends from 1986 to 1992. Int J Epidemiol 1995; 24(5): 1034-1041.
| Crossref | Google Scholar |

Frisse AC, Marrazzo JM, Thtlam NT, et al. Validity of self-reported history of Chlamydia trachomatis infection. Am J Obstet Gynecol 2017; 216(4): 393.e1-393.e7.
| Crossref | Google Scholar |

Horner PJ, Anyalechi GE, Geisler WM. What can serology tell us about the burden of infertility in women caused by chlamydia? J Infect Dis 2021; 224: S80-S85.
| Crossref | Google Scholar | PubMed |

Barbee LA, Soge OO, Khosropour CM, et al. The duration of pharyngeal gonorrhea: a natural history study. Clin Infect Dis 2021; 73(4): 575-582.
| Crossref | Google Scholar | PubMed |

10  Barbee LA, Khosropour CM, Soge OO, et al. The natural history of rectal gonococcal and chlamydial infections: the ExGen study. Clin Infect Dis 2022; 74(9): 1549-1556.
| Crossref | Google Scholar | PubMed |

11  Rahman KS, Darville T, Wiesenfeld HC, Hillier SL, Kaltenboeck B. Mixed Chlamydia trachomatis peptide antigens provide a specific and sensitive single-well colorimetric enzyme-linked immunosorbent assay for detection of human anti-C. trachomatis antibodies. mSphere 2018; 3(6): e00484-18.
| Crossref | Google Scholar |

12  R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2022. Available at https://www.R-project.org/

13  Posit team. RStudio: Integrated Development Environment for R. Posit Software; 2023. Available at http://www.posit.co/

14  Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. J Open Source Softw 2019; 4(43): 1686.
| Crossref | Google Scholar |

15  Grolemund G, Wickham H. Dates and times made easy with lubridate. J Stat Softw 2011; 40(3): 1-25.
| Crossref | Google Scholar |

16  Henry L, Wickham H. rlang: Functions for Base Types and Core R and “Tidyverse” Features. R package version 106; 2022. Available at https://CRAN.R-project.org/package=rlang

17  Öhman H, Rantsi T, Joki-Korpela P, Tiitinen A, Surcel HM. Prevalence and persistence of Chlamydia trachomatis-specific antibodies after occasional and recurrent infections. Sex Transm Infect 2020; 96(4): 277-282.
| Crossref | Google Scholar | PubMed |

18  Alexiou ZW, Van Aar F, Hoenderboom BM, Morre SA, Heijne JCM. Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years. Sex Transm Infect 2023; 100(1): 31-38.
| Crossref | Google Scholar |

19  Blomquist PB, Mighelsen SJ, Wills G, et al. Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections. PLoS One 2018; 13(12): e0208652.
| Crossref | Google Scholar |

20  Geisler WM, Morrison SG, Doemland ML, et al. Immunoglobulin-specific responses to chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection. J Infect Dis 2012; 206(12): 1836-1843.
| Crossref | Google Scholar | PubMed |

21  Vojtech L, Paktinat S, Luu T, et al. Use of viability PCR for detection of live Chlamydia trachomatis in clinical specimens. Front Reprod Health 2023; 5: 1199740.
| Crossref | Google Scholar |

22  O’Campo P, De Boer MA, Faden RR, Gielen AC, Kass N, Chaisson R. Discrepancies between women’s personal interview data and medical record documentation of illicit drug use, sexually transmitted diseases, and HIV infection. Med Care 1992; 30(10): 965-971.
| Google Scholar | PubMed |